Oracle Corporation’s fiscal fourth-quarter 2026 financial results, announced on June 10th, 2026, reveal a corporate strategy heavily reliant on cloud infrastructure and artificial intelligence to drive its next phase of enterprise growth. The corporation achieved record quarterly revenues of $19.2 Billion, representing a 21% year-over-year expansion. This performance was underpinned by a 47% surge in total cloud revenue to $9.9 Billion, with Oracle Cloud Infrastructure (OCI)

The United Kingdom healthcare workforce management platform market is undergoing a profound structural transition in 2026. This evolution is characterised by a rapid shift from fragmented, manual scheduling methods toward automated, cloud-based and intelligence-driven staffing ecosystems. Facing severe cost pressures, systemic personnel deficits and an increasingly burnt-out workforce, National Health Service Trusts and private healthcare operators are adopting integrated

Nelson Advisors is proud to support the Oxford MedTech Society x Google Gemini Clinical Hackathon on 13th June 2026 as a Silver Sponsor.

The European healthcare and medical technology mergers and acquisitions sector is navigating a structural transformation of lasting significance. In the first half of 2025, the market demonstrated a striking divergence in its transactional metrics: overall deal value spiked by 87% to reach €31.8 Billion, even as the total deal count contracted by 8% to 418 transactions compared to the same period in the prior year.

The healthcare technology mergers and acquisitions landscape has transitioned into a regime of industrial maturity, moving decisively past the speculative pricing cycles of the post-pandemic era. During the height of the market peak, high-growth digital health platforms were valued primarily on projected revenue expansion, frequently disregarding long-term margin profiles or underlying product defensibility. This pricing paradigm has been replaced by a rigorous valuation disc

The execution of private equity buy-and-build strategies within the highly fragmented European medical technology distribution sector has reached a new level of scale and complexity. On June 2nd 2026, Nordic private equity firm Axcel announced the simultaneous acquisition of four distinct regional distributors to establish Sanviva, a newly consolidated European medical device distribution network. By pulling Apodan (Denmark), PartnerMed (Norway), AllweCare Medical (Netherland

The landscape of continuous glucose monitoring (CGM) has reached a critical evolutionary inflection point. For more than two decades, the sector was defined by an intensive engineering competition focused on physical biosensor attributes: minimising sensor lag, improving mean absolute relative difference accuracy, reducing wearability profiles and ensuring seamless integration with insulin pumps and closed-loop systems. However, as physical sensors have achieved near-perfect

The European HealthTech sector has seen a surge of momentum, highlighted by a massive growth round addressing one of the industry's biggest bottlenecks: administrative fragmentation and clinical workflow inefficiencies. The European MedTech sector has experienced a highly active week, dominated by fallout from the MedTech Forum 2026 in Stockholm, a major legislative clash over AI regulation, and fresh structural updates designed to make Europe a more attractive market for med

Nelson Advisors partner Lloyd Price was interviewed by Healthcare Business International for their 'What does the £900M NHS AI framework mean for UK healthcare?' story.

The market for Practice Management Software ( Praxisverwaltungssoftware, also referred to as Arztinformationssysteme or AIS) in Germany is undergoing a profound structural transformation. Long characterised by legacy local architectures, fragmented market shares and a highly protective regulatory environment, the sector is experiencing rapid disruption driven by mandatory digitisation laws, the emergence of cloud-native and artificial-intelligence-native platforms, and aggres

Flok Health’s oversubscribed $12.5M Series A round highlights a broader maturation of autonomous clinical AI in regulated medical environments. By securing CQC registration to autonomously diagnose, treat and discharge patients, Flok Health has established a new precedent for digital clinical practice in a single-payer healthcare system.

The definitive agreement announced on March 9th, 2026, for Universal Health Services, Inc. (UHS) to acquire Talkspace, Inc. (TALK) marks a critical milestone in the integration of digital health platforms into traditional brick-and-mortar hospital networks. Under the terms of the Agreement and Plan of Merger, UHS will acquire all outstanding shares of Talkspace for $5.25 per share in an all-cash transaction, representing an enterprise value of approximately $835 Million.

The European healthcare technology and clinical artificial intelligence sectors have transitioned into an era of disciplined industrialisation. The speculative fragmentation and "growth-at-all-costs" investment thesis that characterized the zero-interest-rate policy era have been replaced by a rigorous focus on unit economics, real-world clinical evidence, and deep workflow integration. As the market approaches the second half of 2026, venture capital deployment in clinical A

The release of Anthropic’s Claude Opus 4.8 on May 28th, 2026, represents a significant development in the deployment of frontier artificial intelligence within highly regulated industries, with profound implications for healthcare technology, clinical operations and the life sciences. Built upon a foundation of accelerated model upgrades, Claude Opus 4.8 positions Anthropic at the forefront of the enterprise AI sector. This position is supported by a historic sixty-five billi

In late 2021, amid a broader pandemic-fuelled surge in remote healthcare and virtual care solutions, electronics retailer Best Buy sought to expand its healthcare footprint under its "Best Buy Health" banner. The cornerstone of this healthcare expansion was the acquisition of Current Health, an at-home care and remote patient monitoring platform, for approximately $400 Million. However, by June 2025, the retail giant shifted its strategy, divesting Current Health back to its